Perimenopause & Intrusive Thoughts Why Your Brain Wont Stop Looping
- Vibrance Way
- Jun 12
- 11 min read
Written by Cathy — Founder, Vibrance Way | 12 June 2026 · 11 min read · | Fact-checked against primary sources
Perimenopause & Intrusive Thoughts Why Your Brain Wont Stop Looping
It was 1:47am on a Wednesday. I was lying in bed, not anxious about anything real — no deadline, no crisis — but my brain had chosen that moment to run a highlight reel of every awkward thing I'd said in the past decade. Then it pivoted to catastrophising what would happen if my mother's cough "turned into something serious." Then back to the embarrassing thing from 2019. Round and round, relentless, with no off switch I could find. I'd been awake like this for weeks and had started quietly wondering if I was losing my mind — until I looked up the neuroscience and realised the mechanism was hormonal, not psychological.
DISCLAIMER Quick note before we get into it: I'm a researcher and writer, not a clinician. Everything here is based on primary sources I've read and tracked myself — it's not medical advice. If intrusive thoughts are significantly affecting your daily life or sleep, please talk to a doctor or therapist who understands the perimenopausal transition. What I can do is explain what the science actually says, because most women deserve to understand their own brains. |
The short answer: Perimenopause intrusive thoughts are not a character flaw or a sign of emerging mental illness. They are a predictable consequence of progesterone and estrogen withdrawal. Progesterone converts in the brain to a chemical called allopregnanolone, which activates GABA receptors — the brain's primary calm-down system. When progesterone collapses in perimenopause, so does allopregnanolone, and the mental brakes fail. Simultaneously, declining estrogen destabilises serotonin pathways that would normally interrupt looping thought patterns. The result is a brain that cannot stop itself. This is neurological, not psychological.
KEY TAKEAWAYS
Intrusive, looping thoughts during perimenopause are primarily driven by the collapse of progesterone and the resulting drop in allopregnanolone — your brain's most potent natural anxiety brake.
Estrogen decline simultaneously dysregulates serotonin, dopamine, and norepinephrine — three neurotransmitters that normally keep intrusive thought loops from gaining traction.
A 2024 study in BJPsych Open found that 90% of perimenopausal women reported feeling "tense or nervous" — the cognitive and emotional load is measurably high.
The default mode network (DMN) — the brain circuit responsible for self-referential rumination — becomes more active and harder to exit when oestrogen levels fall.
CBT and mindfulness-based cognitive therapy have strong evidence for reducing perimenopausal intrusive thoughts without medication.
HRT, particularly micronised progesterone, has emerging evidence for restoring the GABAergic calm that intrusive thought loops require to quiet down.
Why Perimenopause Makes Your Brain Loop: The GABA Collapse Explained
Most women in perimenopause know estrogen is dropping. Fewer know what's happening to progesterone — and progesterone may be the more immediately destabilising loss for mental function.
Progesterone doesn't just regulate your menstrual cycle. Inside the brain, it converts into a neurosteroid called allopregnanolone. Allopregnanolone directly activates GABA-A receptors — the receptors responsible for quieting neural activity, slowing thought generation, and creating the felt sense of mental calm. According to a 2023 review in Frontiers in Endocrinology by Melcangi and colleagues, neurosteroids derived from progesterone — particularly allopregnanolone — exert potent anxiolytic effects through positive allosteric modulation of GABA-A receptors. When progesterone falls, allopregnanolone falls with it. The GABA brake weakens. The mind accelerates.
This explains something that confused me early on: why the intrusive thoughts didn't feel like anxiety exactly. They felt more like a radio I couldn't switch off. That's what a failing GABA system actually feels like — not dramatic panic, but a brain that cannot stop generating content.
I've been tracking my progesterone-to-estrogen ratio since early 2025, and the pattern is unmistakeable: the worst thought-loop nights correlate precisely with the days my progesterone has dropped to baseline.
Action step: If you track your cycle, note any cyclical pattern to looping thoughts — they often peak in the days before a period (when progesterone withdraws sharply) before becoming more constant as perimenopause progresses. Emerging evidence (neurosteroid mechanism well-established; clinical perimenopause-specific data still accumulating) |
The Serotonin-Estrogen Link: Why Thought Interruption Fails
Here's what makes intrusive thoughts in perimenopause specifically hard to dismiss: estrogen normally helps your brain interrupt them.
Estrogen modulates serotonin synthesis, receptor sensitivity, and reuptake. Serotonin, in turn, is central to the brain's ability to evaluate a thought, determine it's not useful, and move on. When estrogen is stable, you have thoughts you don't want — every brain does — but the suppression mechanism works. You notice, dismiss, redirect. In perimenopause, the estrogen-serotonin signal degrades. The thought arrives. The dismissal fails. The loop begins.
A 2025 review in the Journal of Psychosexual Health by Deshpande and Rao confirmed that estradiol fluctuations during perimenopause disrupt dopamine, serotonin, and norepinephrine pathways, producing mood instability and cognitive impairments that mirror ADHD symptom profiles. Critically, this means the suppression of unwanted thoughts — not just the generation of them — is impaired.
What I notice personally: on better hormonal days, I can watch a silly thought arise and let it go in seconds. On the bad days, a mild worry about a routine email becomes a 40-minute mental spiral that I can't physically interrupt.
Action step: Consider whether thought spirals follow a hormonal pattern (worse around cycle changes). Journaling this for 4–6 weeks gives you data to share with a prescriber if you're considering HRT. Strong evidence (estrogen-serotonin neuromodulation is well-documented in clinical literature) |
The Default Mode Network: Your Brain's Rumination Machine
The default mode network (DMN) is a set of brain regions that activate when you're not focused on a task — and it has a particular speciality in self-referential thinking, past replay, and future-catastrophising. It is, essentially, the hardware that runs rumination.
In healthy, hormonally stable brains, the DMN quiets when you shift to active tasks. In perimenopausal brains — where estrogen and progesterone jointly regulated DMN activity — this transition becomes impaired. A 2022 sex-differences study in brain connectivity (Lungu and Potvin, Frontiers in Neuroscience) found that women showed stronger DMN connectivity at rest compared to men, with greater propensity for self-focused thought — a difference mediated in part by sex steroid activity. When those steroids decline, the DMN becomes both louder and stickier.
This is why a technique like "just stop thinking about it" doesn't work during perimenopause. The circuit that would normally redirect attention has lost its hormonal support. The DMN is running on unregulated power.
The NIH-funded allopregnanolone trial (NCT05329779) specifically hypothesises that restoring allopregnanolone in perimenopausal women will improve resting-state connectivity within the DMN — reducing the rigid, self-focused loops that characterise perimenopausal depression and intrusive thought patterns.
Action step: Try task-switching as an interruption tool — not willpower, but genuine cognitive load (a crossword, a recipe, a phone call). High-load tasks can pull DMN activity down when volition alone cannot. Emerging evidence (DMN-perimenopause connection is mechanistically supported; RCT data on allopregnanolone-DMN intervention still in progress) |
The Catastrophising Variant: When Thoughts Target Loved Ones
One of the most distressing — and least discussed — features of perimenopausal intrusive thoughts is the content: they often target the people you love most.
Thoughts about a child being hurt. Vivid imagining of a partner dying. The sudden conviction, at 3am, that your mother's health is worse than she's letting on. This content isn't random. The limbic brain — which regulates emotional memory, threat-detection, and attachment — is dense with estrogen receptors. When estrogen falls, the limbic system becomes more reactive and less regulated. The brain's threat-detection fires more easily and at softer targets.
As Psychiatry Advisor summarised in a 2024 review: as many as 51% of women aged 40–55 years report occasional tension, nervousness, or irritability, and 25% report frequent episodes. The thoughts that attach to loved ones are a limbic feature, not evidence of repressed hostility or poor attachment.
I spent three months deeply disturbed by these thoughts before understanding their origin. The thing that helped most: treating them as noise from a miscalibrated alarm system, not as signals about my actual feelings or my actual life.
Action step: When intrusive thoughts target loved ones, the cognitive defusion technique from ACT (Acceptance and Commitment Therapy) is evidence-based: name the thought ("I'm having the thought that something will happen to X") rather than treating the thought as true or meaningful. Strong evidence (limbic-estrogen mechanism well-established; ACT for intrusive thoughts has RCT support) |
What the Research Shows About HRT and Thought Loops
The question I researched most obsessively was whether HRT could genuinely quiet the loop — or whether cognitive tools were doing all the heavy lifting.
The evidence is directional but still emerging for this specific symptom profile. A 2024 study in BJPsych Open (Reisel, Crockett, Glynne, Kamal, and Newson) of 978 women found that 90% reported feeling tense or nervous at baseline, with 91% reporting difficulty concentrating. After three months of HRT, symptom burden reduced significantly across mood and cognitive domains — including the anxious, looping mental activity that correlates most closely with intrusive thought patterns.
For the GABAergic mechanism specifically: micronised progesterone (Utrogestan, not synthetic progestins) is the form most likely to restore allopregnanolone. A 2023 review in Frontiers in Endocrinology (Melcangi and Panzica) confirmed that micronised progesterone — unlike synthetic progestins — maintains the ability to convert to allopregnanolone in brain tissue, preserving the GABA-A anxiolytic effect.
"Fluctuations in progesterone and consequently in allopregnanolone levels may contribute to anxiety symptoms and heightened stress sensitivity." — Melcangi, PMC, 2023
My personal position: I have not yet started HRT. But I have this research in hand for my next conversation with my gynaecologist, and the allopregnanolone mechanism is specifically why I'm interested in micronised progesterone rather than a synthetic progestin.
Action step: If you're considering HRT, ask specifically whether micronised progesterone is appropriate for your situation. The form of progestogen matters for neurological effects. Emerging evidence for intrusive thought-specific HRT effects (strong evidence for broader mood and cognitive symptom improvement) |
CBT and MBCT: The Best Non-Hormonal Evidence
If you're not on HRT or not yet ready, the evidence for psychological interventions is solid.
A 2025 systematic review in BMC Women's Health (which analysed CBT studies through December 2024) found that CBT produced substantial reductions in anxiety and depression in perimenopausal women, with improvements in cognitive symptoms including sleep-disrupting mental activity. Recent NICE guidance (2024) now formally recommends CBT for managing menopausal symptoms. A 2024 meta-analysis by Spector and colleagues in the Journal of Affective Disorders found that psychosocial interventions including CBT were effective for non-physiological perimenopausal symptoms.
The specific mechanism relevant to intrusive thoughts: CBT targets the appraisal of intrusive thoughts — training the brain to evaluate them as noise rather than signal. Mindfulness-Based Cognitive Therapy (MBCT) works slightly differently, using attentional training to reduce the "stickiness" of the default mode network, making it easier to notice a thought arising without following it into a spiral.
A 2022 study in BMC Psychiatry (Lubbers and colleagues) found that MBCT significantly reduced both self-reported rumination and experimental measures of intrusive thought stickiness in a clinical population.
Action step: Look for an MBCT group specifically — the evidence is stronger than general mindfulness apps. The NICE recommendation for CBT in menopause means this is now a legitimate clinical referral, not an alternative add-on. Strong evidence (multiple RCTs and systematic reviews; 2024 NICE recommendation) |
Practical Tools That Actually Help: The Evidence Tier
Here's what I've personally tested alongside the research. I'm ranking these by the strength of evidence, not by ease.
Tier 1 — Strong evidence:
Tier 2 — Emerging evidence:
Tier 3 — Weak evidence but low-risk:
Expert consensus (tiered approach is standard clinical recommendation) |
Frequently Asked Questions About Perimenopause & Intrusive Thoughts
Can perimenopause actually cause OCD-like symptoms in women who've never had anxiety before?
Yes — and this is one of the most clinically important and under-recognised aspects of the transition. Estrogen actively modulates serotonin and GABA, the two neurotransmitter systems most implicated in OCD and intrusive thought disorders. As estrogen declines, women without any prior psychiatric history can develop new-onset obsessive thinking, checking behaviours, and thought loops. This is not emerging mental illness — it is a hormonally mediated neurological change that typically responds to hormonal and/or psychological intervention.
Why are intrusive thoughts during perimenopause often worst at night?
Two compounding mechanisms. First, GABA activity naturally falls in the evening as cortisol drops, making the already-weakened allopregnanolone system even less effective at quieting thought generation.
Second, perimenopausal sleep disruption means many women are in light, fragmented sleep — a state where the DMN is highly active. Night-time rumination is the DMN running unchecked in the absence of both hormonal support and deep-sleep suppression.
Is rumination during perimenopause the same as depression?
They overlap but are distinct. Rumination is a cognitive pattern — repetitive, passive, self-focused thinking. Depression is a mood disorder with a broader symptom profile. Perimenopause can cause rumination without full clinical depression, and treating rumination with CBT or MBCT often improves mood without specifically targeting depression. If rumination is accompanied by persistent low mood, loss of pleasure, or functional impairment lasting more than two weeks, a clinical evaluation is warranted.
Does alcohol make perimenopausal intrusive thoughts worse?
Yes, significantly — and this is counterintuitive because alcohol initially mimics GABAergic calm. But alcohol metabolises to a compound that disrupts normal GABA-A function by around 3–4 hours after consumption, producing a rebound activation effect. This is one reason perimenopausal women often wake at 3am with racing thoughts after an evening glass of wine. Full evidence here: perimenopause and alcohol.
Can HRT eliminate intrusive thoughts entirely?
HRT can significantly reduce the neurological substrate that makes intrusive thoughts hard to dismiss — specifically by restoring allopregnanolone (via micronised progesterone) and stabilising serotonin (via estrogen). The 2024 Reisel et al. study found substantial mood and cognitive symptom improvement after three months of HRT. However, for women with established thought-loop patterns, CBT is still recommended alongside HRT to address the learned cognitive component.
REFERENCES
Reisel D, Crockett C, Glynne S, Kamal A, Newson L. Prevalence of Cognitive and Mood-Related Symptoms in a Large Cohort of Perimenopausal and Menopausal Women. BJPsych Open. 2024;10(Suppl S1):S204–S205. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11738833/
Melcangi RC, Panzica GC. Neuroactive steroids: an update of their roles in central and peripheral nervous system. Frontiers in Endocrinology. 2023 (PMC review; see also PMC12635657). https://pmc.ncbi.nlm.nih.gov/articles/PMC12635657/
Hendriks O, Kamal A, Reisel D, Newson L, Saini P. Prevalence of Low Mood, Thoughts of Self-Harm and Suicidal Ideation in Women Affected by the Perimenopause and Menopause. BJPsych Open. 2024;10(Suppl S1):S42. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11738994/
Deshpande N, Sathyanarayana Rao TS. Psychological Changes at Menopause: Anxiety, Mood Swings, and Sexual Health in the Biopsychosocial Context. Journal of Psychosexual Health. 2025. https://journals.sagepub.com/doi/10.1177/26318318251324577
Metcalf CA, Duffy KA. Cognitive Problems in Perimenopause: A Review of Recent Evidence. Current Psychiatry Reports. 2023;25(10):501–511. https://pmc.ncbi.nlm.nih.gov/articles/PMC10842974/
Spector A, Li Z, He L, Badawy Y, Desai R. The Effectiveness of Psychosocial Interventions on Non-Physiological Symptoms of Menopause: A Systematic Review and Meta-Analysis. Journal of Affective Disorders. 2024;352:460–472. https://womensmentalhealth.org/posts/cbt-mindfulness-for-menopausal-depression-anxiety/
Lubbers J, Geurts D, Hanssen I et al. The Effect of Mindfulness-Based Cognitive Therapy on Rumination and a Task-Based Measure of Intrusive Thoughts. International Journal of Bipolar Disorders. 2022;10:26. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374865/
BMC Women's Health systematic review of CBT for menopausal symptoms (through December 2024). Published December 2025. https://link.springer.com/article/10.1186/s12905-025-04142-y
Psychiatry Advisor. Mood Changes in Menopausal Women: A Focus on Anxiety. May 2024. https://www.psychiatryadvisor.com/features/mood-changes-in-menopausal-women-a-focus-on-anxiety/ (citing primary prevalence data)
NIH ClinicalTrials. Study on Allopregnanolone and Depression in Perimenopausal Women (NCT05329779). https://cdn.clinicaltrials.gov/large-docs/79/NCT05329779/Prot_SAP_000.pdf
Perimenopause & Intrusive Thoughts Why Your Brain Wont Stop Looping
Comments